Traditional prognostic factors for breast cancer are tumor size, axillary lymph node status, lymphatic and vascular invasion, hormone receptor status, and expression of human epidermal growth factor receptor 2 (HER2), but they do not fully reflect the prognosis of breast cancer [3,7,8]. This evidence concerns the gene ERBB2 and breast carcinoma.